In short
Strongyloidiasis is a parasitic infection that can remain hidden for decades, often showing no symptoms at all. However, understanding who needs testing and when is crucial, as this condition can turn life-threatening in people with weakened immune systems. The diagnostic journey involves specialized tests that look for tiny worms or the body's response to them, but finding the infection isn't always straightforward.
Key points
- About half of people infected with Strongyloides have no symptoms at all, making testing based on risk factors rather than symptoms crucial for prevention of complications.
- Single stool tests miss most strongyloidiasis cases—detecting only 30% of infections—so multiple samples and different testing methods are often necessary.
- The infection can hide in your body for over 30 years without causing problems, then suddenly become deadly if you start taking immunosuppressive medications.
- Blood antibody tests are more sensitive than stool examination, detecting 80-97% of infections, but can't distinguish between current infection and past exposure.
- Anyone who has lived in tropical or subtropical regions should discuss strongyloidiasis testing before starting corticosteroids or other drugs that weaken the immune system.
- Hyperinfection syndrome kills 60-70% of people who develop it, but is almost entirely preventable through screening and treatment before starting immunosuppressive therapy.
- Newer PCR tests that detect parasite DNA are more sensitive than traditional methods but aren't yet widely available in all healthcare facilities.
- Clinical trials typically require multiple positive tests and baseline measurements before enrollment to ensure accurate assessment of new treatments.
Introduction: When to Seek Diagnostics
Figuring out if you have strongyloidiasis can be tricky because many infected people feel perfectly healthy. In fact, about half of all infections cause no noticeable symptoms at all. This makes knowing when to get tested particularly important, especially since the infection can persist for your entire lifetime without treatment due to a unique feature called autoinfection, where the parasites can reinfect you from within your own body.
You should consider undergoing diagnostics if you have lived in or traveled to tropical and subtropical regions, particularly Southeast Asia, the Western Pacific, parts of Africa, Central and South America, or rural areas of the southern United States. These are the places where Strongyloides stercoralis, the roundworm that causes this disease, lives in contaminated soil.
Testing becomes especially urgent if you are about to begin treatment with corticosteroids or other medications that suppress your immune system. These drugs can transform a quiet, long-standing infection into a medical emergency called hyperinfection syndrome, where the worms multiply rapidly and spread throughout your body. Healthcare providers should be particularly careful to consider testing in people who have certain blood cancers like leukemia or lymphoma, those receiving organ transplants, or anyone infected with human T-cell lymphotropic virus type 1 (HTLV-1).
Certain symptoms should also prompt you to seek testing. These include unexplained stomach pain, diarrhea that comes and goes, a persistent cough, unusual skin rashes (especially a distinctive snake-like pattern called larva currens), or if blood tests show an elevated level of white blood cells called eosinophils. However, these symptoms can be quite vague and similar to many other conditions, which is why doctors need to maintain a high level of suspicion based on your background and risk factors.
Classic Diagnostic Methods
Diagnosing strongyloidiasis requires finding evidence of the Strongyloides worms in your body or detecting your immune system's response to them. Unfortunately, no single test is perfect, and doctors often need to use multiple approaches to confirm the diagnosis. The main challenge is that infected people typically have very small numbers of worms, making them hard to detect.
Stool Examination
The most traditional method involves examining stool samples under a microscope to look for rhabditiform larvae, which are the immature form of the worms. However, this test has a significant limitation: it detects the infection in only about 30% of cases when a single stool sample is examined. The problem is that larvae are not consistently shed in every bowel movement, so they can easily be missed. To improve the chances of detection, doctors typically request at least three separate stool samples collected on different days.
A more sensitive technique called the agar plate culture method can be used. In this approach, fresh stool is placed on a special plate containing nutrients. If larvae are present, they crawl across the plate and leave visible tracks, and they can grow into larger, more easily identifiable forms. This method is significantly better than simple microscopy, but it requires fresh samples and specialized equipment that isn't available everywhere.
Blood Tests for Antibodies
Blood tests that detect antibodies—proteins your immune system makes in response to the infection—are generally more sensitive than stool examinations. These serological tests can identify 80% to 97% of people with strongyloidiasis. The advantage is that antibodies remain in your blood even when larvae aren't being shed in your stool, making the infection easier to detect.
However, antibody tests have their own limitations. They can remain positive for months or even years after successful treatment, so they can't distinguish between current and past infections. They may also show false-positive results in people infected with other parasitic worms, since the immune response to different parasites can look similar. Additionally, these tests are less reliable in people with severely weakened immune systems, who may not produce enough antibodies to be detected even when they're infected.
Examination of Other Body Fluids
When strongyloidiasis spreads beyond the intestines, larvae may be found in other places. In cases of severe infection, doctors might examine sputum (the mucus you cough up from your lungs) under a microscope to look for worms. During hyperinfection syndrome, when the parasite burden becomes overwhelming, larvae can sometimes be found in samples taken during procedures like bronchoscopy, where a tube with a camera is inserted into the airways to collect fluid from the lungs.
In the digestive system, more invasive procedures can help. An endoscopy—where a flexible tube with a camera is passed through your mouth into your stomach and small intestine—allows doctors to directly see the lining of your digestive tract. They can take small tissue samples called biopsies, which are then examined under a microscope. In some cases, fluid can be aspirated (sucked out) from the small intestine where adult worms live, and this fluid can be examined for larvae.
Complete Blood Count
A routine blood test called a complete blood count (CBC) can provide an important clue. Many people with strongyloidiasis have elevated levels of eosinophils, a type of white blood cell that increases in response to parasitic infections. This condition is called eosinophilia. However, eosinophilia is not specific to strongyloidiasis—it can occur with many other conditions, including allergies and other parasitic infections. Moreover, people with hyperinfection syndrome and very weak immune systems may not show eosinophilia at all, even though they have severe disease.
Molecular Tests
Newer diagnostic methods use polymerase chain reaction (PCR) technology to detect the genetic material (DNA) of Strongyloides worms in stool or other samples. These molecular tests can be more sensitive than traditional microscopy and can sometimes detect infection when other methods fail. PCR tests are particularly promising because they can identify very small numbers of parasites. However, these tests are not yet widely available in all healthcare settings, and there is still work to be done to standardize the procedures across different laboratories.
Distinguishing Strongyloides from Other Parasites
When examining stool samples under a microscope, it's important to distinguish Strongyloides larvae from those of hookworms, another type of intestinal parasite. The two can look similar, but there are key differences in their physical features. Strongyloides larvae have a short mouth cavity and a notch in the tail, while hookworm larvae have a longer mouth cavity and a pointed tail. This distinction is critical because the infections are treated differently and have different implications for your health.
Diagnostics for Clinical Trial Qualification
When researchers conduct clinical trials to test new treatments for strongyloidiasis, they need very specific criteria to determine who can participate. These enrollment criteria typically include proven infection status and other factors that help ensure the study results are reliable and meaningful.
For most clinical trials studying strongyloidiasis treatments, participants must have confirmed infection through one of the standard diagnostic methods. This usually means either detecting larvae in stool samples through microscopy or culture methods, or having positive antibody test results. Some trials may require multiple positive tests to ensure that participants truly have the infection rather than false-positive results.
Trials often establish baseline measurements before treatment begins. This includes documenting the number of larvae found in stool samples if parasites are detected directly, measuring antibody levels if using serological tests, and recording eosinophil counts from blood tests. These baseline values help researchers determine whether the treatment is working by comparing results before and after therapy.
For studies focusing on severe forms of the disease, enrollment may specifically require evidence of hyperinfection syndrome or disseminated strongyloidiasis. This would involve finding larvae in unusual locations like sputum, blood, or other organs beyond the gastrointestinal tract, along with clinical signs of severe illness such as respiratory distress, shock, or organ failure.
Many trials also require screening for other conditions that might affect the results or put participants at risk. This includes testing for HIV infection, HTLV-1 infection, or other factors that affect immune function. Some studies exclude people taking certain medications, particularly corticosteroids or other immunosuppressants, because these drugs can dramatically change how the disease behaves and responds to treatment.
Follow-up testing during and after treatment is standard in clinical trials. Researchers typically examine stool samples at regular intervals—often at two weeks, four weeks, and several months after treatment—to see if larvae are still present. Antibody levels may also be monitored over time, as successful treatment should lead to gradually declining antibody levels over six months to a year. Some newer trials are exploring the use of PCR tests to detect parasite DNA, as these might provide earlier evidence of treatment success or failure.
Prognosis and Survival Rate
Prognosis
The outlook for people with strongyloidiasis varies dramatically depending on their immune status and whether they receive treatment. For individuals with normal immune systems who receive appropriate treatment, the prognosis is generally excellent. Most people can be successfully cured with antiparasitic medications, and the infection causes no lasting health problems.
Without treatment, the prognosis is quite different. Because of the unique ability of Strongyloides to cause autoinfection, the infection can persist for the person's entire lifetime—even decades after they've left an area where the parasite is found. People have been documented with chronic infections lasting 30 years or more. While many of these individuals remain without symptoms throughout this time, the infection represents a constant risk that could become dangerous if their immune system weakens.
The development of hyperinfection syndrome or disseminated strongyloidiasis represents a medical emergency with a very serious outlook. These severe forms of the disease occur almost exclusively in people whose immune systems are compromised, particularly those taking corticosteroids or other immunosuppressive medications, people with HTLV-1 infection, or those with certain blood cancers. When hyperinfection develops, the worms multiply uncontrollably and spread throughout the body, causing organ failure, overwhelming bacterial infections, and shock.
Survival Rate
Survival rates for strongyloidiasis depend entirely on the severity of the infection and how quickly treatment begins. For uncomplicated strongyloidiasis in people with normal immune function who receive appropriate treatment, survival is essentially 100%. These infections are readily curable, and death from the disease in this setting is extremely rare.
The picture changes drastically with hyperinfection syndrome and disseminated strongyloidiasis. These severe forms of the disease carry a mortality rate of 60% to 70%, meaning that six or seven out of every ten people with these complications die despite treatment. This high death rate reflects both the overwhelming nature of the infection when it spreads throughout the body and the fact that it occurs in people who already have weakened immune systems from other serious conditions.
Early recognition and treatment are critical for improving survival in severe cases. When hyperinfection is caught early and treated aggressively with antiparasitic medications—and when immunosuppressive drugs can be stopped or reduced—some patients can be saved. However, once multiple organs begin to fail and severe bacterial infections develop alongside the parasitic infection, survival becomes increasingly unlikely despite intensive medical care.
